751
Participants
Start Date
February 13, 2007
Primary Completion Date
March 17, 2008
Study Completion Date
July 25, 2008
Boostrix ® Polio
One dose of vaccine administered intramuscularly
GSK Biologicals' HPV-16/18 L1 AS04 vaccine (Cervarix TM)
Three doses of vaccine administered intramuscularly, with the second and third dose give one month and six months after the first dose respectively
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Évreux
GSK Investigational Site, Pont-de-l'Arche
GSK Investigational Site, Madrid
GSK Investigational Site, Hanover
GSK Investigational Site, Hanover
GSK Investigational Site, Pamplona
GSK Investigational Site, Auch
GSK Investigational Site, Tours
GSK Investigational Site, Luynes
GSK Investigational Site, Wolfenbüttel
GSK Investigational Site, Seville
GSK Investigational Site, Montbrison
GSK Investigational Site, Essey-lès-Nancy
GSK Investigational Site, Vieux-Condé
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Mannheim
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Rouen
GSK Investigational Site, Karlsruhe
GSK Investigational Site, Rheinstetten
GSK Investigational Site, Le Havre
GSK Investigational Site, Offenburg
GSK Investigational Site, Kehl
GSK Investigational Site, Ettenheim
GSK Investigational Site, Munich
GSK Investigational Site, Toulon
GSK Investigational Site, Draguignan
GSK Investigational Site, Ravensburg
GSK Investigational Site, Würzburg
GSK Investigational Site, Nordhausen
GSK Investigational Site, Nice
GSK Investigational Site, Leipzig
Lead Sponsor
GlaxoSmithKline
INDUSTRY